Death receptor 5-mediated TNFR family signaling pathways modulate γ-humulene-induced apoptosis in human colorectal cancer HT29 cells

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 419-424

  Lan, Y U Hsuan ^a   Wu, Yang Chang ^a   Wu, Kai Wei ^a   Chung, Jing Gung ^a   Lu, Chi Cheng ^c   Chen, Yuan Liang ^d   Wu, Tian Shung ^a   Yang, Jai Sing ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d YUANPEI UNIVERSITY   (Taiwan)

Author keywords

; humulene; Death receptor 5; Herbal medicine; Human colorectal cancer ht29 cells; Tnfr family apoptotic signaling

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; DEATH RECEPTOR 5; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; GAMMA CARYOPHYLLENE; HUMULENE; PROCASPASE 3; PROCASPASE 8; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRAIN HT29; CELL STRUCTURE; CELL VIABILITY; EMILIA SONCHIFOLIA; HUMAN; HUMAN CELL; MEDICINAL PLANT; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; APOPTOSIS; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HT29 CELLS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SESQUITERPENES; SIGNAL TRANSDUCTION;

EID: 78651365608     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1087     Document Type: Article

References (29)

1. Ocvirk J, Brodowicz T, Wrba F, et al: Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial. World J Gastroenterol 16: 3133-3143, 2010.
2. Laszlo L and Tamas N: The development of the first line treatment of metastatic colorectal cancer (mCRC). Magy Onkol 53: 237-246, 2009.
3. Gravalos C, Garcia-Escobar I, Garcia-Alfonso P, Cassinello J, Malon D and Carrato A: Adjuvant chemotherapy for stages II, III and IV of colon cancer. Clin Transl Oncol 11: 526-533, 2009.
4. Rocken C: Molecular targets for colon cancer. VEGF, EGFR, and what else? Pathologe 29 (Suppl. 2): 200-203, 2008.
5. Latruffe N, Delmas D, Jannin B, Cherkaoui Malki M, Passilly- Degrace P and Berlot JP: Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent. Int J Mol Med 10: 755-760, 2002.
6. Lee JY, Huerta-Yepez S, Vega M, Baritaki S, Spandidos DA and Bonavida B: The NO TRAIL to YES TRAIL in cancer therapy (Review). Int J Oncol 31: 685-691, 2007.
7. Bonavida B, Ng CP, Jazirehi A, Schiller G and Mizutani Y: Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review). Int J Oncol 15: 793-802, 1999.
8. Eid MA, Lewis RW, Abdel-Mageed AB and Kumar MV: Reduced response of prostate cancer cells to TRAIL is modulated by NFkappaB-mediated inhibition of caspases and Bid activation. Int J Oncol 21: 111-117, 2002.
9. Chaudhari BR, Murphy RF and Agrawal DK: Following the TRAIL to apoptosis. Immunol Res 35: 249-262, 2006.
10. Bagnoli M, Canevari S and Mezzanzanica D: Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer. Int J Biochem Cell Biol 42: 210-213, 2010.
11. Shylesh BS and Padikkala J: In vitro cytotoxic and antitumor property of Emilia sonchifolia (L.) DC in mice. J Ethnopharmacol 73: 495-500, 2000.
12. Muko KN and Ohiri FC: A preliminary study on the antiinflammatory properties of Emilia sonchifolia leaf extracts. Fitoterapia 71: 65-68, 2000.
13. Shylesh BS and Padikkala J: Antioxidant and anti-inflammatory activity of Emilia sonchifolia. Fitoterapia 70: 275-278, 1999.
14. Tang YJ, Yang JS, Lin CF, et al: Houttuynia cordata Thunb extract induces apoptosis through mitochondrial-dependent pathway in HT-29 human colon adenocarcinoma cells. Oncol Rep 22: 1051-1056, 2009.
15. Chang YH, Yang JS, Kuo SC and Chung JG: Induction of mitotic arrest and apoptosis by a novel synthetic quinolone analogue, CWC-8, via intrinsic and extrinsic apoptotic pathways in human osteogenic sarcoma U-2 OS cells. Anticancer Res 29: 3139-3148, 2009.
16. Chou LC, Yang JS, Huang LJ, et al: The synthesized 2-(2- fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells. J Gastroenterol 44: 1055-1063, 2009.
17. Lu HF, Lai KC, Hsu SC, et al: Curcumin induces apoptosis through FAS and FADD, in caspase-3-dependent and -independent pathways in the N18 mouse-rat hybrid retina ganglion cells. Oncol Rep 22: 97-104, 2009.
18. Yodkeeree S, Sung B, Limtrakul P and Aggarwal BB: Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species. Cancer Res 69: 6581-6589, 2009.
19. Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC and Chung JG: MJ-29 inhibits tubulin polymerization, induces mitotic arrest and triggers apoptosis via CDK1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J Pharmacol Exp Ther 334: 477-488, 2010.
20. Lo C, Lai TY, Yang JH, et al: Gallic acid induces apoptosis in A375.S2 human melanoma cells through caspase-dependent and -independent pathways. Int J Oncol 37: 377-385, 2010.
21. Irving BA, Weltman JY, Brock DW, Davis CK, Gaesser GA and Weltman A: NIH ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity (Silver Spring) 15: 370-376, 2007.
22. Borner MM: Molecular targets in colon cancer. Ther Umsch 63: 243-248, 2006.
23. Huerta S, Goulet EJ and Livingston EH: Colon cancer and apoptosis. Am J Surg 191: 517-526, 2006.
24. Tao J, Di L, Wen H, Zhao X, Shan J and Cai B: Investigation of research method of fingerprint pharmacodynamics of traditional Chinese medicines. Zhongguo Zhong Yao Za Zhi 34: 2410-2413, 2009.
25. Tan KY, Liu CB, Chen AH, Ding YJ, Jin HY and Seow-Choen F: The role of traditional Chinese medicine in colorectal cancer treatment. Tech Coloproctol 12: 1-6, 2008. (Pubitemid 351782224)
26. Kawahara K, Oyadomari S, Gotoh T, Kohsaka S, Nakayama H and Mori M: Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells. FEBS Lett 506: 135-139, 2001. (Pubitemid 32925215)
27. Chen JJ, Chou CW, Chang YF and Chen CC: Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation. J Immunol 180: 8030-8039, 2008.
28. Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F and de Jong S: Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys Acta 1805: 123-140, 2010.
29. Billen LP, Shamas-Din A and Andrews DW: Bid: a Bax-like BH3 protein. Oncogene 27 (Suppl. 1): S93-S104, 2008.